Herombopag for the Prevention of Radio-chemotherapy Induced Thrombocytopenia in Cervical Cancer

NCT06745219 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Thrombopenia
Cervical Cancer
Radiotherapy Side Effect
Chemotherapeutic Toxicity

Interventions

DRUG: herombopag

Sponsor

Peking University Cancer Hospital & Institute